[Skip to Content]
Sign In
Individual Sign In
Create an Account
Institutional Sign In
OpenAthens Shibboleth
Purchase Options:
[Skip to Content Landing]

Reprint Orders

Standards for AMA Publishing Group
Reprints and e-Prints Purchased by Organizations

The JAMA Network offers a variety of reprint and e-print options. Single articles, as well as collections of articles from a single issue or several issues of JAMA Network journals, are available in both paper and electronic formats. JAMA Network reprints are an essential educational resource for your customers and staff, and a valuable sales tool for use at medical conferences or on your intranet or website.

Contact us to find the right JAMA Network resource for your needs:

Sue Lovenberg, Manager
JAMA Network Reprint & e-Print Communications
Sue.Lovenberg@jamanetwork.com
973-263-9191 ext. 218
Requests from non-profit organizations, AMA members, medical societies, and academic institutions. Bulk reprint requests for JAMA Cardiology, JAMA Facial Plastic Surgery, JAMA Oncology, JAMA Otolaryngology-Head & Neck Surgery, JAMA Pediatrics, and JAMA Surgery.

Marsha Fogler, Account Manager
JAMA Network Reprint Sales
Marsha.Fogler@jamanetwork.com
USA: 1-800-482-1450
Rest of World: 1-856-489-4446
Bulk reprint requests for JAMA, JAMA Internal Medicine, JAMA Dermatology, JAMA Ophthalmology, JAMA Neurology, and JAMA Psychiatry

General Inquiries:
JAMA Network Reprints Communications

reprints@jamanetwork.com
Phone: 1-312-464-0776

General Policies

Fundamental Principles

The JAMA Network strives to produce medical research and information that adheres to the highest professional standards. The JAMA Network editorial process is designed to ensure that all published information is timely, rigorously peer-reviewed, and clinically relevant.

Reprints may not imply endorsement of a product or influence by an organization. Each reprint request is subject to approval by The JAMA Network, which reserves the right to reject orders deemed not in keeping with our standards.

Back to top

Ownership of Copyright

Materials published in JAMA Network journals, including subsequent translations, are owned and copyrighted by the American Medical Association (AMA). Materials under AMA copyright remain the property of the AMA and may not be reproduced in any form without written permission from the publisher. The AMA encourages reporting of any suspected unauthorized use to the AMA. The AMA is responsible for securing all necessary permissions.

Back to top

Content

All JAMA Network editorial content must be reproduced verbatim for a reprint or e-print. Any reprints or e-prints of content that has been corrected should incorporate that correction either at the end of the article or as a notation. No content is available for reprints or e-prints prior to publication in a JAMA Network journal. Articles published online ahead of print may be purchased as e-prints or reprints on the date they are published online, provided they meet all the criteria listed above.

In the event that a correction is necessary for an article, reprints or e-prints of the article will be unavailable until the correction is published.

Back to top

Purchase Agreement

The purchaser should submit a written request, a letter of agreement, or a purchase order specifying the type of product (reprint or e-print, single article or collection), quantity, use, and audience.

Back to top

Product-Specific Policy and Procedures

Single-Article Reprints in Paper Format

The policies outlined below apply to paper reprints of a single JAMA Network article or multiple related articles from a single issue as indicated by an editorial notation (eg, an Original Investigation that refers to a Commentary, Editorial, etc).

Policy and Procedures

  1. Single-article reprints are subject to The JAMA Network Fundamental Principles and approval.
  2. With rare exceptions, reprints must include a front cover that includes the following:
    • Name/logo of journal
    • The JAMA Network logo
    • Title of article, complete list of authors, and issue date
    • The phrase "Reprint Article" or its translation must appear at the top of the cover. No other content is permitted on the front cover.
  3. Reprints must also include the original running footer plus the following information:
    • "(Reprinted) Journal Name" and copyright information.
  4. Prescribing information or disclaimers required or approved by a government regulatory body (eg, US Food and Drug Administration [FDA]) or the purchasing company's inventory numbers may be included subject to The JAMA Network Fundamental Principles and approval. When prescribing information is required, the printed product will consist of the article followed by a buffer page and then the prescribing information. The buffer page will include a statement similar to the following:
    • "This reprint is provided courtesy of [company name], which has a financial interest in the product/topic discussed in this article. The following FDA-approved labeling has been provided by [company name]. [Journal Name] and the AMA do not assume responsibility for the content of the following information."
    • Note: the above statement is permitted only on the buffer page for approved prescribing information.
  5. Reprint holders and all materials contained therein (cover letters and other materials printed as part of, attached to, or surrounding a reprint) are subject to JAMA Network Fundamental Principles and approval.
  6. No promotional material may be included with or attached to the reprint.
  7. The following disclosure, or its translation, may be included in 8-pt type on the bottom of the non-content back cover page.
    • "This reprint is provided courtesy of [company name], which has a financial interest in the product/topic discussed in this article."

Back to top

Web and Other Electronic Formats (GreenPrints)

The policies outlined below apply to JAMA Network journals e-Prints, which are currently available in 2 formats:

Policy and Procedures
Organizations may purchase JAMA Network journals e-Prints under the conditions outlined in the Fundamental Principles section and under the following product-specific conditions:

  1. E-print requests, including the webpage or email message that links to the article, are subject to JAMA Network Fundamental Principles and approval.
  2. The requested e-print must adhere to the following criteria:
    • The content of the article PDF will not be altered.
    • The link must include the full citation to the article (ie, author, title, and journal name, year, volume, issue, pages, or DOI if the article has been published online ahead of print).
    • The name of the company sponsoring the website or email message must be clearly displayed.
    • Webpage or email may not use the AMA trademark or logo and shall not suggest that the AMA promotes or otherwise endorses any third party products, business relationships, services, causes, campaigns, websites, content, or information.
    • After JAMA Network approval, the link and the information surrounding the link must not be changed without prior approval.
  3. Following approval, access will be granted to the electronic article.

Back to top

Access to a PDF-Based e-Print Residing on the AMA e-Prints Dedicated Server

Purchasing organizations wishing to link to an AMA Journal article PDF may purchase access to that PDF for a specific number of accesses or length of time, provided that the above stipulations are met. A URL link will be provided to enable the purchasing organization to establish password-free access from the supporting company's linking page to the e-print PDF. The purchasing organization will maintain this link for the duration of the agreement.

Back to top

Access to a Rights-Protected, Free standing PDF-based e-Print

This e-print is a downloadable rights-protected PDF of the article(s) that is similar in appearance to a paper reprint.

Rights-protected PDF-based e-Prints will include the cover page and running footer requirements described in the paper-format reprint section Single Article Reprint of these standards.

Prescribing information or disclaimers required or approved by a government regulatory body (eg, FDA) may be included with a PDF e-print subject to The JAMA Network Fundamental Principles and approval process. When prescribing information is included, a buffer page with disclaimer information (described in Single-Article Reprints, Paper Format, Item 4) will be required. Such information will be attached to the original article PDF and then locked (rights protected) prior to delivery.

The company web site and specific page and/or e-mail from which the rights-protected PDF e-print will link are subject to The JAMA Network Fundamental Principles and AMA e-print criteria.

An organization may purchase multiple e-prints on a related subject. These e-prints may be packaged together via links or bundled into a single rights-protected PDF. When these electronic packages consist of articles not related by editorial notation in the original publication, they will be subject to The JAMA Network Fundamental Principles and product-specific conditions approval process.

Back to top

The JAMA Network Journals Reprint Collections

The policies outlined below apply to collections of articles drawn from a single issue or multiple issues of JAMA Network journals. These products may be in print or electronic format.

Policy and Procedures

  1. JAMA Network Reprint Collections are subject to JAMA Network Fundamental Principles and approval. They must also meet the following product-specific conditions:
    • The customer selects a topic, core article, or selection of articles for a reprint collection and submits a request to The JAMA Network.
    • The JAMA Network proposal will include the selected articles, the proposed purchaser(s) and distribution mechanism(s), along with a PDF mock-up of the design for approval.
    • No promotional material for a product or activity involving the purchasing organization may be included with or attached to the Reprint Collection.
  2. Prescribing information or disclaimers required or approved by a government regulatory body (eg, US Food and Drug Administration [FDA]) or the purchasing company's inventory numbers may be included subject to The JAMA Network Fundamental Principles and approval. When prescribing information is required, the printed product will consist of the article followed by a buffer page and then the prescribing information. The buffer page will include a statement similar to the following:
    • "This reprint is provided courtesy of [company name], which has a financial interest in the product/topic discussed in this article. The following FDA-approved labeling has been provided by [company name]. [Journal Name] and the AMA do not assume responsibility for the content of the following information."
    • Note: the above statement is permitted only on the buffer page for approved prescribing information.
  3. Reprint holders and all materials contained therein (cover letters and other materials printed as part of, attached to, or surrounding a reprint) are subject to The JAMA Network Fundamental Principles and approval.

Back to top

×